EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)ÄquivalenzstudieMultizentrische Studie

Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation

Atul Verma iD, David H Birnie, Chenyang Jiang, Hein Heidbüchel, Gerhard Hindricks, Paulus Kirchhof, Jeff S Healey iD, Yunhe Wang, Nikolaos Dagres, Marc W Deyell, Prashanthan Sanders, Rajeev K Pathak und 18 weitere

New England Journal of Medicine · 22.01.2026 · 394 (4) · 323-332

DOI: 10.1056/nejmoa2509688 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift New England Journal of Medicine, erschienen am 22.01.2026. Verfasst von Atul Verma und 29 weiteren Autor:innen. Beteiligte Einrichtung: McGill University Health Centre, McGill University, Montreal. Hauptthemen laut MEDLINE: Aspirin, Atrial Fibrillation, Catheter Ablation, Factor Xa Inhibitors. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Canadian Stroke Prevention Network, Rosenfeld Heart Foundation, Brain-Heart Interconnectome Canada First Research Excellence Fund Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinAtrial FibrillationCatheter AblationFactor Xa InhibitorsFibrinolytic AgentsRivaroxabanStrokeAgedFemaleHumansMaleMiddle AgedAdministration, OralBrainEmbolismFollow-Up StudiesHemorrhageIncidenceKaplan-Meier EstimateMagnetic Resonance ImagingTreatment OutcomeProspective Studies

Substanzen

AspirinFactor Xa InhibitorsFibrinolytic AgentsRivaroxaban

Autor:innen und Institutionen

  • McGill University Health Centre, McGill University, Montreal.
  • University of Ottawa Heart Institute, Ottawa.
  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, China.
  • University Hospital Antwerp, Antwerp, Belgium.
  • Deutches Herzzentrum der Charité, Universitätsmedizin Berlin, member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin.
  • Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

ORCID-Profile: Atul Verma, Jeff S Healey, Michael D Hill

Förderung

  • Canadian Stroke Prevention Network
  • Rosenfeld Heart Foundation
  • Brain-Heart Interconnectome Canada First Research Excellence Fund Grant
  • Bayer
  • Abbott Cardiovascular
  • Biotronik
  • University of Ottawa Accelerate Funding Program
  • Canadian Institutes of Health Research

Zitieren

APA

Verma, A., Birnie, D. H., Jiang, C., Heidbüchel, H., Hindricks, G., Kirchhof, P., Healey, J. S., Wang, Y., Dagres, N., Deyell, M. W., Sanders, P., Pathak, R. K., Koopman, P., Nuyens, D., Novak, P., Amit, G., Dussault, C., Makanjee, B., Quinn, F. R., …, & OCEAN Investigators (2026). Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation. New England Journal of Medicine, 394(4), 323-332. https://doi.org/10.1056/nejmoa2509688

Vancouver

Verma A, Birnie DH, Jiang C, Heidbüchel H, Hindricks G, Kirchhof P, et al. Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation. New England Journal of Medicine. 2026;394(4):323-332. doi:10.1056/nejmoa2509688

BibTeX
@article{Verma2026,
  author = {Verma, Atul and Birnie, David H and Jiang, Chenyang and Heidbüchel, Hein and Hindricks, Gerhard and Kirchhof, Paulus and Healey, Jeff S and Wang, Yunhe and Dagres, Nikolaos and Deyell, Marc W and Sanders, Prashanthan and Pathak, Rajeev K and Koopman, Pieter and Nuyens, Dieter and Novak, Paul and Amit, Guy and Dussault, Charles and Makanjee, Bhavanesh and Quinn, F Russell and Jolly, Umjeet and Iden, Leon and Kuniss, Malte and Sharma, Mukul and Ha, Andrew and Essebag, Vidal and Champagne, Jean and Hill, Michael D and Smith, Eric E and Wells, George A and OCEAN Investigators, OCEAN Investigators},
  title = {Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {4},
  pages = {323--332},
  doi = {10.1056/nejmoa2509688}
}
Kostenlos starten →